Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Sales | 13,360 | 15,416 | 3,022 | 2,839 | 962 |
| Cost of Goods | 0 | 2,312 | 2,087 | 2,163 | 0 |
| Gross Profit | 13,360 | 13,104 | 1,200 | 676 | 962 |
| Operating Expenses | 25,640 | 26,055 | 10,440 | 4,863 | 0 |
| Operating Income | -12,280 | -12,951 | -9,505 | -4,187 | 962 |
| Interest Expense | 3 | 222 | 225 | 216 | 0 |
| Other Income | 3 | 0 | 259 | 116 | 0 |
| Pre-tax Income | -12,280 | -13,173 | -9,470 | -4,287 | 962 |
| Net Income Continuous | -12,284 | -13,173 | -9,470 | -4,287 | -3,970 |
| Net Income Discontinuous | -30 | 0 | 0 | 0 | 0 |
| Net Income | $-12,310 | $-13,173 | $-9,470 | $-4,287 | $-3,970 |
| EPS Basic Total Ops | -4.36 | -5.84 | -7.68 | -4.44 | -4.28 |
| EPS Basic Continuous Ops | -4.36 | -5.83 | -7.69 | -4.44 | -4.28 |
| EPS Basic Discontinuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -4.36 | -5.84 | -7.68 | -4.44 | -4.28 |
| EPS Diluted Continuous Ops | -4.36 | -5.83 | -7.69 | -4.44 | -4.28 |
| EPS Diluted Discontinuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-11,930 | $-12,568 | $-9,155 | $-3,870 | $962 |